Literature DB >> 15082351

Aerobic bacterial isolates from burn wound infections and their antibiograms--a five-year study.

N Agnihotri1, V Gupta, R M Joshi.   

Abstract

A retrospective study of major aerobic bacterial isolates from pus/wound swabs taken from patients admitted to the burn unit at Govt. Medical College Hospital, Chandigarh, India, over a period of 5 years (June 1997-May 2002) was undertaken. The study was carried out to determine the bacterial profile and antimicrobial susceptibility of the isolates and to describe the change in trends over the study period. The pus/wound swabs yielded very high culture positivity (96%) for 665 total isolates. Pseudomonas aeruginosa was found to be most common isolate (59%) followed by Staphylococcus aureus (17.9%), Acinetobacter spp. (7.2%), Klebsiella spp. (3.9%), Enterobacter spp. (3.9%), Proteus spp. (3.3%) and others (4.8%). Although P. aeruginosa continued to remain the predominant isolate over the five years, a constant and significant increase in the incidence of Acinetobacter spp. was found. Amikacin was found to be the most effective drug against gram negative bacteria, however, resistance to it was significantly increased over 5 years. For S. aureus and P. aeruginosa netilmicin and piperacillin were found to be the most effective drugs. Most of the isolates showed high level resistance to antimicrobial agents.

Entities:  

Mesh:

Year:  2004        PMID: 15082351     DOI: 10.1016/j.burns.2003.11.010

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  36 in total

1.  Prevalence of beta lactamase producing species of pseudomonas and acinetobacter in pediatric burn patients.

Authors:  B Sobouti; N Khosravi; A Daneshvar; S Fallah; M Moradi; Y Ghavami
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

2.  Study on biofilm formation in burn wound infection in a pediatric hospital in Chennai, India.

Authors:  M Ramakrishnan; S Putli Bai; M Babu
Journal:  Ann Burns Fire Disasters       Date:  2016-12-31

3.  Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in mice.

Authors:  Hassan Heydari Farsani; Iraj Rasooli; Seyed Latif Mousavi Gargari; Shahram Nazarian; Shakiba Darwish Alipour Astaneh
Journal:  World J Methodol       Date:  2015-12-26

4.  Prevalence of biofilm producing aerobic bacterial isolates in burn wound infections at a tertiary care hospital in northern India.

Authors:  S Asati; U Chaudhary
Journal:  Ann Burns Fire Disasters       Date:  2017-03-31

5.  Laboratory-based evaluation of MDR strains of Pseudomonas in patients with acute burn injuries.

Authors:  Hong-Tu Zhang; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  What should be the antibiotic prescription protocol for burn patients admitted in the department of burns, plastic and reconstructive surgery.

Authors:  Mohd Altaf Mir; Mohammad Fahud Khurram; Arshad Hafiz Khan
Journal:  Int Wound J       Date:  2016-03-10       Impact factor: 3.315

7.  Insulin increases resistance to burn wound infection-associated sepsis.

Authors:  Gerd G Gauglitz; Tracy E Toliver-Kinsky; Felicia N Williams; Juquan Song; Weihua Cui; David N Herndon; Marc G Jeschke
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

8.  Bacteriology of the burn wound at the Bai Jerbai Wadia Hospital for children, Mumbai, India-A 13-year study, Part I-Bacteriological profile.

Authors:  Shankar Srinivasan; Arvind M Vartak; Aakanksha Patil; Jovita Saldanha
Journal:  Indian J Plast Surg       Date:  2009-07

9.  Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution.

Authors:  Indu Biswal; Balvinder Singh Arora; Dimple Kasana
Journal:  J Clin Diagn Res       Date:  2014-05-15

10.  Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.

Authors:  Ali Manafi; Jamshid Kohanteb; Davood Mehrabani; Aziz Japoni; Masoud Amini; Mohsen Naghmachi; Ahmad Hosseinzadeh Zaghi; Nazanin Khalili
Journal:  BMC Microbiol       Date:  2009-02-01       Impact factor: 4.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.